Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:2108-2114
Published online before print September 2, 2004, doi: 10.1161/01.ATV.0000143857.27408.de
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
24/11/2108    most recent
01.ATV.0000143857.27408.dev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robinson, S. D.
Right arrow Articles by Hodivala-Dilke, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robinson, S. D.
Right arrow Articles by Hodivala-Dilke, K. M.
Related Collections
Right arrow Other Vascular biology
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:2108.)
© 2004 American Heart Association, Inc.


Vascular Biology

ß3-Integrin Regulates Vascular Endothelial Growth Factor-A–Dependent Permeability

Stephen D. Robinson; Louise E. Reynolds; Lorenza Wyder; Daniel J. Hicklin; Kairbaan M. Hodivala-Dilke

From the Cell Adhesion and Disease/Tumour Biology Laboratory (S.D.R., L.E.R., K.M.H.-D.), Cancer Research UK Clinical Centre, Queen Mary’s School of Medicine & Dentistry at Barts & The London, John Vane Science Centre, Charterhouse Square, London; Novartis Institute for Biomedical Research (L.W.), Angiogenesis Programme, Basel, Switzerland; and ImClone Systems Inc (D.J.H.), New York, NY.

Correspondence to Stephen D. Robinson, Cell Adhesion and Disease/Tumour Biology Laboratory, Cancer Research UK Clinical Centre, Queen Mary’s School of Medicine & Dentistry at Barts & The London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, United Kingdom. E-mail s.d.robinson{at}cancer.org.uk

Objective— ß3-integrin deficiency has been implicated in increasing levels of Flk-1 expression on endothelial cells and enhancing vascular endothelial growth factor (VEGF)-induced angiogenesis. We determined the role of ß3-integrin in mediating VEGF-A–induced blood vessel permeability through Flk-1.

Methods and Results— Using the Miles assay, we demonstrated that VEGF-A–induced plasma leakage was enhanced in ß3-null mice when compared with wild-type controls. This was not caused by any changes in blood vessel structure (as detected by light or electron microscopy) or by changes in endothelial cell–cell adhesion proteins (as determined by Western blot analysis, flow cytometry, and immunofluorescence). Circulating levels of VEGF, baseline blood vessel leakage, and leakage in response to an acute inflammatory stimulus were identical in wild-type and ß3-null mice. However, VEGF-A–induced leakage was abolished in ß3-null mice by the inhibition of Flk-1, indicating that the elevated levels of Flk-1 on ß3-null endothelial cells enhance VEGF-A–induced permeability.

Conclusions— ß3-integrin–deficiency increases the sensitivity of endothelial cells to VEGF-A by elevating Flk-1 expression and, as a consequence, enhances VEGF-A–mediated permeability.

Blood vessels in ß3-integrin–deficient mice are histologically normal and functionally intact. However, they express elevated levels of Flk-1 and are more sensitive than wild-type blood vessels to VEGF-A–induced permeability, but not to permeability induced by acute inflammatory agents.


Key Words: ß3-integrin • VEGF • Flk-1 • permeability • endothelium




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Silva, G. D'Amico, K. M. Hodivala-Dilke, and L. E. Reynolds
Integrins: The Keys to Unlocking Angiogenesis
Arterioscler. Thromb. Vasc. Biol., October 1, 2008; 28(10): 1703 - 1713.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. N. Gavrilovskaya, E. E. Gorbunova, N. A. Mackow, and E. R. Mackow
Hantaviruses Direct Endothelial Cell Permeability by Sensitizing Cells to the Vascular Permeability Factor VEGF, while Angiopoietin 1 and Sphingosine 1-Phosphate Inhibit Hantavirus-Directed Permeability
J. Virol., June 15, 2008; 82(12): 5797 - 5806.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. M. Weis, J. N. Lindquist, L. A. Barnes, K. M. Lutu-Fuga, J. Cui, M. R. Wood, and D. A. Cheresh
Cooperation between VEGF and {beta}3 integrin during cardiac vascular development
Blood, March 1, 2007; 109(5): 1962 - 1970.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
G. H. Mahabeleshwar, W. Feng, D. R. Phillips, and T. V. Byzova
Integrin signaling is critical for pathological angiogenesis
J. Exp. Med., October 30, 2006; 203(11): 2495 - 2507.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
X. Zhang, Z. Xiong, Y. Wu, W. Cai, J. R. Tseng, S. S. Gambhir, and X. Chen
Quantitative PET Imaging of Tumor Integrin {alpha}v{beta}3 Expression with 18F-FRGD2
J. Nucl. Med., January 1, 2006; 47(1): 113 - 121.
[Abstract] [Full Text] [PDF]